Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News ACADIA Pharmaceuticals Inc ACAD

Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders... see more

Recent & Breaking News (NDAQ:ACAD)

4 Election-Proof Stocks: Biotech And Software Take The Lead

Benzinga.com  November 8, 2016

15 Biggest Mid-Day Gainers For Tuesday

Benzinga.com  November 8, 2016

Benzinga's Volume Movers

Benzinga.com  November 8, 2016

ACADIA Pharmaceuticals Reports Third Quarter 2016 Financial Results

Business Wire November 7, 2016

InvestorsObserver releases covered-call reports for ACADIA Pharmaceuticals, Valero Energy, Kite Pharma, Inovio Pharmaceuticals and Fitbit

PR Newswire November 7, 2016

16 Stocks Moving In Monday's Pre-Market Session

Benzinga.com  November 7, 2016

ACADIA Pharmaceuticals Initiates Phase III Trial of Pimavanserin for Adjunctive Treatment in Patients with Schizophrenia

Business Wire November 3, 2016

ACADIA Pharmaceuticals to Announce Third Quarter 2016 Financial Results on November 7, 2016

Business Wire November 1, 2016

ACADIA Pharmaceuticals Initiates Phase II Study of Pimavanserin in Alzheimer’s Disease Agitation

Business Wire October 31, 2016

Learn how to target a 16% return on Apple, or get option-trade ideas on ACADIA Pharmaceuticals, Yamana Gold Inc., Level 3 Communications and Western Digital or any stock you choose

PR Newswire October 28, 2016

Covered Call reports for ACADIA Pharmaceuticals, Spark Therapeutics, Valero Energy, Lululemon and CSX include trade ideas that offer returns of 20% or more!

PR Newswire October 14, 2016

ACADIA Pharmaceuticals Receives California Life Sciences Association’s 2016 Pantheon DiNA Award for Outstanding Therapeutic Product for NUPLAZID™

Business Wire October 11, 2016

Watch These 7 Huge Call Purchases In Thursday Trade

Benzinga.com  October 6, 2016

Benzinga's M&A Chatter for Wednesday September 28, 2016

Benzinga.com  September 28, 2016

InvestorsObserver releases covered-call reports for MetLife Incorporated, NIKE, Bitauto Holdings, United Parcel Service and ACADIA Pharmaceuticals

PR Newswire September 28, 2016

ACADIA Pharmaceuticals to Present at the Ladenburg Thalmann 2016 Healthcare Conference on September 27, 2016

Business Wire September 20, 2016

ACADIA Pharmaceuticals Sponsors National Parkinson Foundation’s Caregiver Summit

Business Wire September 19, 2016

ACADIA Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference on September 12, 2016

Business Wire September 6, 2016

ACADIA Pharmaceuticals Announces Appointment of Todd S. Young as Executive Vice President, Chief Financial Officer

Business Wire August 24, 2016

ACADIA Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares

Business Wire August 23, 2016